By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Silence Therapeutics plc 

Centre Point
103 New Oxford Street
London    WC 1A 1DD  United Kingdom
Phone: 44-0-20-73071620 Fax: 44-0-20-73071680


SEARCH JOBS


Industry
Biotechnology






Company News
MiReven, Silence Therapeutics plc Ink Collaboration 8/22/2012 11:00:58 AM
Silence Therapeutics plc - Admission of Shares and Board Update 8/2/2012 1:10:23 PM
Silence Therapeutics plc Announces Safe and Effective Dose Successfully Identified in Phase I Study of Atu027 and Potential Fund Raising 6/6/2012 11:01:30 AM
New Data from Silence Therapeutics plc's Atu027 Anticancer Trial Published at American Society of Clinical Oncology 5/17/2012 10:47:40 AM
Silence Therapeutics plc' Partner, Quark Pharmaceuticals Inc., Extends its Agreement With Pfizer Inc. (PFE) to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 5/3/2012 7:02:19 AM
Silence Therapeutics plc: Unaudited Preliminary Results for the Year Ended 31 December 2011 3/21/2012 10:27:17 AM
Silence Therapeutics plc Forms Scientific Advisory Board and Forms Two New Research Collaborations to Further Strengthen Liver Pipeline 3/21/2012 10:22:34 AM
Silence Therapeutics plc and Other Opponents of Tuschl I Patent Succeed in Limiting Scope and Ambiguity in the Patent 3/9/2012 10:11:05 AM
Silence Therapeutics plc Announces Board Changes and Appointment of New Chief Executive Officer 2/10/2012 6:33:23 AM
Silence Therapeutics plc Signs Collaboration with miRagen Therapeutics to Evaluate Delivery of Novel microRNA-based Therapeutics 1/9/2012 10:34:16 AM
1234567
//-->